Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death

Citation
J. Van Beek et al., Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death, NEUROREPORT, 12(2), 2001, pp. 289-293
Citations number
24
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROREPORT
ISSN journal
09594965 → ACNP
Volume
12
Issue
2
Year of publication
2001
Pages
289 - 293
Database
ISI
SICI code
0959-4965(20010212)12:2<289:CACISP>2.0.ZU;2-O
Abstract
The anaphylatoxin C3a is a potent inflammatory polypeptide released at site s of complement activation. To test whether C3a might alter neuronal outcom e following an ischemic insult, we determined the effects of purified human C3a on murine primary cortical cell cultures exposed to apoptotic or excit otoxic paradigms. C3a prevented neither serum deprivation-induced apoptotic neuronal death, nor AMPA/kainate-mediated excitotoxicity. However, in mixe d cultures of neurons and astrocytes, Ca dose-dependently protected neurons against NMDA toxicity (47% neuroprotection using 100 nM C3a, p< 0.01, n = 12). The neuroprotective effect of C3a was observable only in the presence of astrocytes. These observations suggest that C3a is involved in excitotox icity-mediated neuronal death through astrocyte stimulation and extend its role beyond immune functions. NeuroReport 12:289-293 (C) 2001 Lippincott Wi lliams & Wilkins.